2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma, Non-Hodgkin
17
Neuroblastoma
16
Leukemia, Myeloid, Acute
14
Leukemia
13
Hodgkin Disease
13
Central Nervous System Neoplasms
13
Small Cell Lung Carcinoma
10
Sarcoma
9
Brain Neoplasms
9
Recurrence
8
Medulloblastoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Rhabdoid Tumor
7
Multiple Myeloma
7
Lymphoma, B-Cell
7
Lung Neoplasms
7
Burkitt Lymphoma
7
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Astrocytoma
6
Teratoma
5
Ovarian Neoplasms
5
Neoplasms, Germ Cell and Embryonal
5
Neoplasms
5
Glioma
5
Interventions
Magnetic Resonance Spectroscopy
7
X-Rays
6
Specimen Handling
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
trametinib
3
fludarabine
3
dabrafenib
3
Tacrolimus
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
ulixertinib
2
tipifarnib
2
thymoglobulin
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
erdafitinib
2
ensartinib
2
Whole-Body Irradiation
2
Vemurafenib
2
Rituximab
2
Mycophenolic Acid
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
etoposide phosphate
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled